Cabinet approves first drug under new process
Ibrutinib is used to treat patients with a common form of leukaemia
The cabinet approved its first medicine under the state’s new drug approval process this week.
Ibrutinib, which is used to treat patients with a common form of leukaemia, is manufactured by Janssen and marketed as Imbruvica.
As the medicine exceeded a certain cost threshold the final decision on its approval had to be made by Minister for Health Simon Harris and his cabinet colleagues.
Subscribe from just €1 for the first month!
With any subscription you will have access to
Unlimited multi-device access to our iPad, iPhone and Android Apps
Unlimited access to our eReader library
Exclusive daily insight and opinion seven days a week
Create alerts to never miss a subject that matters to you
Get access to exclusive offers for subscribers on gifts and experiences
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine
Children prescribed adult doses of drugs at Kerry mental health centre
Parents of one child have launched legal proceedings against the HSE and an investigation is under way over treatment of up to 400 children between 2016 and 2020
Patients with rare diseases urge Dáil to pass law on orphan drugs
Three years after a bill on the issue was first proposed, patients say they are tired of agonising delays to accessing life-changing treatments
Contractor’s claims against children’s hospital could add €446m to project
The board of National Children’s Hospital has set aside €15 million to defend 906 claims made by BAM